Access
To read this story in full you will need to login or make a payment (see right).
Outlook
Nature 449, 160-163 (13 September 2007) | doi:10.1038/449160a; Published online 12 September 2007
Open Innovation Challenges
-
Direct Molecular Detection of Proteins and Nucleic Acids
This Challenge is looking for novel approaches to protein and nucleic acid detection. This is an Id...
-
Single-cell Analysis Platform
This Challenge is looking for novel approaches to analyzing changes at a single-cell level. This is...
nature jobs
Chocolate Food Technologists
- Nestlé
- Broc, Switzerland
Chair, Department of Informatic Medicine and Personalized Health
- University of Missouri-Kansas City
- Kansas City, Missouri, USA
Neglected Diseases A tough transition
Peter A. Singer1, Kathryn Berndtson1, C. Shawn Tracy1, Emma R. M. Cohen1, Hassan Masum1, James V. Lavery2 & Abdallah S. Daar1
Abstract
What is holding back biotechnology in the developing world? Peter A. Singer and his colleagues listen to those on the ground.
The path from basic scientific discovery to effective therapy is rarely rapid or simple, especially in the developing world. Making this transition easier is a sizeable and pressing problem.
To read this story in full you will need to login or make a payment (see right).

